Zobrazeno 1 - 10
of 26
pro vyhledávání: '"E. U Asymbekova"'
Publikováno v:
КардиоСоматика, Vol 6, Iss 3, Pp 33-37 (2015)
Metabolic syndrome represents a combination of different major risk factors of cardiovascular diseases and is mainly related to impaired insulin sensitivity in biological tissues. Common understanding of pathogenesis and relationship of different pat
Externí odkaz:
https://doaj.org/article/4437ed826cb04217968cb145d5bb54c1
Autor:
M. A. Alekseeva, P. V. Vartanov, E. U. Asymbekova, V. I. loshina, I. P. Shuvaev, Yu. I. Buziashvili
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 6, Pp 39-42 (2018)
Progression of atherosclerosis in patients with coronary artery disease (CAD) who underwent surgical treatment, manifests itself in the development of dysfunction of the shunts, and in worsening of the condition of native coronary arteries. According
Externí odkaz:
https://doaj.org/article/53ea991cd6c6466592f37f9575f58f2e
Autor:
S T Matskeplishvili, B M Borbodoeva, E U Asymbekova, A Z Rakhimov, N K Akhmedyarova, K B Kataeva, Yu I Buziashvili
Publikováno v:
Терапевтический архив, Vol 89, Iss 4, Pp 22-28 (2017)
Aim. To study of the impact of shock-wave therapy (SWT) on the functional status of patients with coronary heart disease (CHD). Subjects and methods. Thirty-four CHD patients (including 33 men) with left ventricular (LV) asynergic segments, as eviden
Externí odkaz:
https://doaj.org/article/da7719cae1f14d23a9359bae0f7261d2
Autor:
J. I. Buziashvili, I. S. Stilidi, E. U. Asymbekova, S. T. Mackeplishvili, E. F. Tugeeva, N. K. Ahmedyarova, E. V. Artamonova, F. R. Akildzhonov
Publikováno v:
Medical alphabet. :26-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc127eaf50f4f6f0329f5d98efaf9d9f
https://doi.org/10.33667/2078-5631-2022-13-26-31
https://doi.org/10.33667/2078-5631-2022-13-26-31
Publikováno v:
Medical alphabet. :49-53
Along with the rapid development of molecular genetic testing, immunotherapy and targeted antitumor therapy in Oncology, the risk of cardiotoxicity associated with chemotherapy remains a keystone that directly affects the survival and quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fd13305d25148b4e590f0e837e704f4
https://doi.org/10.33667/2078-5631-2021-19-49-53
https://doi.org/10.33667/2078-5631-2021-19-49-53
Autor:
G. G. Kvaratskheliya, E. P. Golubev, U. S. Avkhadov, R. M. Ibragimov, B. E. Rustamov, E. U. Asymbekova, L. S. Shakhnazaryan, Yu. I. Buziashvili
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 25, Iss 2, Pp 95-101 (2021)
В кардиохирургических центрах сформировались различные взгляды на ушивание перикарда. Научных данных, подтверждающих преимущество то
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::3249feb8a5cef58d7f875049938b0760
http://journalmeshalkin.ru/index.php/heartjournal/article/view/964
http://journalmeshalkin.ru/index.php/heartjournal/article/view/964
Autor:
Yu I Buziashvili, E U Asymbekova, S T Matskeplishvili, E F Tugeeva, L L Nersesyants, L R Barkalaya, I P Shuvaev
Publikováno v:
Сахарный диабет, Vol 11, Iss 1, Pp 35-39 (2008)
Цель. Оценка эффективности стентирования коронарных артерий у больных ИБС и сахарным диабетом. Материалы и методы. В исследование включ
Externí odkaz:
https://doaj.org/article/f997f7e6c6cc47ccb691ab3f8220ba8b
Autor:
N. S. Buslenko, Yu. I. Buziashvili, I. V. Koksheneva, E. U. Asymbekova, O. M. Sherstyannikova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 4, Iss 5, Pp 23-31 (2005)
Aim. To study right ventricular (RV) geometry and analyze clinico-pathophysiological processes, associated with right heart remodeling in coronary heart disease (CHD) patients. Material and methods. The study included 184 CHD patients, who underwent
Externí odkaz:
https://doaj.org/article/5d1d5e2f8e514598b229bdea939e2f32
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 4, Iss 5, Pp 37-43 (2005)
Aim. To assess diagnostic potential of contrast stress echocardiography (CS-EchoCG) with dipyridamole in coronary heart disease (CHD) patients. Material and methods. The study included 22 patients (mean age 56.04±1.8 years) with typical CHD clinics.
Externí odkaz:
https://doaj.org/article/b42cdf84045f428e88640c5bdd09dce4
Autor:
Y. I. Buziashvili, S. T. Matskeplishvili, E. U. Asymbekova, I. H. Hapiy, T. V. Burduli, O. S. Sherbakova, V. I. Buvaltsev
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 67-71 (2003)
There is a great number of coronary patients to whom traditional methods of myocardium revascularization are not indicated. Addition of dipyridamol to traditional antianginal treatment promotes improvement of clinical features of the disease and decr
Externí odkaz:
https://doaj.org/article/8ff6eb96b32d461b8e40eceacf7ec919